VSIR and non-small cell lung carcinoma: Emerging evidence suggests that VISTA, in addition to its surface expression, accumulates within the cytoplasm of various tumor cells, including breast and non-small cell lung cancer (NSCLC), where it may interact with IGSF11 to initiate intracellular signaling pathways that support tumor cell proliferation.